Management of persistent ductus arteriosus in very premature neonates. Results of the French TRIOCAPI trial, perspectives for clinicians, and subsequent studies on this topic
Arch Pediatr
.
2021 Oct;28(7):501-503.
doi: 10.1016/j.arcped.2021.07.002.
Epub 2021 Sep 9.
Authors
G Cambonie
1
,
Ronald I Clyman
2
,
J-C Rozé
3
Affiliations
1
Department of Neonatology, Montpellier University Hospital, 34295 Montpellier, France. Electronic address: g-cambonie@chu-montpellier.fr.
2
Department of Pediatrics and Cardiovascular Research Institute, University of California San Francisco, San Francisco, CA, USA.
3
Department of Neonatology, Nantes University Hospital, 44000 Nantes, France.
PMID:
34511277
DOI:
10.1016/j.arcped.2021.07.002
No abstract available
Keywords:
Echocardiography; Patent ductus arteriosus; Premature birth.
Publication types
Editorial
MeSH terms
Clinical Trials as Topic
Ductus Arteriosus*
Ductus Arteriosus, Patent* / drug therapy
Humans
Infant, Newborn
Infant, Premature